Pharmaceuticals in Germany - Research and Markets

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The German pharmaceuticals market registered revenues of $87.2 billion in 2023, representing a compound annual growth rate (CAGR) of 5.2% between 2018 and 2023.
Germany captured the largest share of the European pharmaceuticals market in 2023, accounting for a share of 23.5%.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Germany
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Germany pharmaceuticals market by value in 2023?
What will be the size of the Germany pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Germany pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Germany's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the strategies of the leading players?
7.4. What are the recent developments in the market?

8 Company Profiles

8.1. Bayer AG
8.2. Boehringer Ingelheim GmbH
8.3. F. Hoffmann-La Roche Ltd

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Germany pharmaceuticals market value: $ billion, 2018-23
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Germany pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: Bayer AG: Key Facts
Table 5: Bayer AG: Annual Financial Ratios
Table 6: Bayer AG: Key Employees
Table 7: Bayer AG: Key Employees Continued
Table 8: Boehringer Ingelheim GmbH: Key Facts
Table 9: Boehringer Ingelheim GmbH: Key Employees
Table 10: F. Hoffmann-La Roche Ltd: Key Facts
Table 11: F. Hoffmann-La Roche Ltd: Key Employees
Table 12: Germany Size of Population (million), 2019-23
Table 13: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 14: Germany GDP (Current Prices, $ Billion), 2019-23
Table 15: Germany Inflation, 2019-23
Table 16: Germany Consumer Price Index (Absolute), 2019-23
Table 17: Germany exchange rate, 2018-23

List of Figures

Figure 1: Germany pharmaceuticals market value: $ billion, 2018-23
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 3: Germany pharmaceuticals market value forecast: $ billion, 2023-28
Figure 4: Forces driving competition in the pharmaceuticals market in Germany, 2023
Figure 5: Drivers of buyer power in the pharmaceuticals market in Germany, 2023
Figure 6: Drivers of supplier power in the pharmaceuticals market in Germany, 2023
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2023
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2023
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Bayer AG
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€323EUR$350USD£274GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€484EUR$525USD£411GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€646EUR$700USD£548GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceutical Industry Outlook, 2024

Pharmaceutical Validation Services Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

Pharmaceuticals Market in Germany 2024-2028

Pharmaceuticals in Europe

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2019-2028